2026 T1D Conf Morris Icovamenib, Improves Endogenous Insulin Secretion in T1D

Biomea Fusion Inc. published this content on September 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 28, 2026 at 09:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]